CME Outfitters Pain Management Symposium to be held December 7th at the North American Neuromodulation Society 17th Annual Meeting and Live Via Web Stream

Share Article

CME Outfitters’ lunchtime symposium at the North American Neuromodulation Society 17th Annual Meeting features expert faculty presentation about managing chronic pain through use of intrathecal delivery.

CME Outfitters (CMEO) announces a Pain Management medical meeting symposium to be held at the North American Neuromodulation Society (NANS) 17th Annual Meeting December 7, 2013 at 12:30pm PST. The CME-certified symposium is entitled Translating Algorithms to Clinical Practice in the Management of Patients With Chronic Pain: Focus on Intrathecal Delivery. To attend the live symposium in person, participants must be registered for the NANS annual meeting. For clinicians unable to attend the live NANS meeting, CMEO welcomes participation via live web stream on December 7, 12:30pm PST.

Optimal pain management is a national health care priority, and the use of opioid therapy for patients with both acute and chronic pain is safer and more effective than ever before. For many patients with severe and intractable chronic pain, oral opioid therapy is not enough and other options are better suited for achieving pain control. Intrathecal (IT) therapy is becoming an increasingly accepted strategy for delivering opioid and non-opioid analgesics, as well as neuromodulators, for the management of intractable pain in appropriate patients. Evidence suggests that ongoing education is warranted identify the appropriate patient and to build and strengthen the use of evidence-based, best practices among clinicians regarding use of IT in pain management.

Click here to register for the symposium live web stream, or visit the NANS website to register for the live meeting.

The symposium will address the following learning objectives:

  •     Apply appropriate patient selection criteria to select candidates for intrathecal analgesia to maximize clinical benefit.
  •     Utilize algorithms for appropriate, long-term treatment selection and monitoring for progression for chronic pain management.
  •     Implement a slow, dose-titration strategy for intrathecal analgesia that maximizes efficacy while minimizing the potential for side effects.
  •     Devise a strategy to overcome barriers that hinder the use of intrathecal analgesia, such as cost and reimbursement issues.

David L. Caraway, MD, PhD
Medical Director
Center for Pain Releif
St. Mary's Regional Medical Center
First Executive Vice President
American Society of Interventional Pain Physicians
Huntington, WV

Eric Grigsby, MD, MBA
Founder and Medical Director
Napa Pain Institute
Neurovations Clinical Research
Napa, CA

Anesthesiologists, pain specialists, and other clinicians whose scope of practice includes providing care to patients with intractable pain.

Supported by an educational grant from Jazz Pharmaceuticals, Inc.

CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME Outfitters, LLC, designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE Credit (Nurses):
Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.0 contact hour. This program is approved for pharmacology credit.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Activity Number: 0376-0000-13-017-L01-P (live programs)
Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations must be completed online at (requires free account activation), and participants can print their certificate or statement of credit immediately (80% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit

This program is not affiliated with NANS.

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CME/CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CME/CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Caraway has disclosed that he has received research and grant support from Bioness Inc.; CNS Therapeutics, Inc.; Jazz Pharmaceuticals, Inc.; Medtronic, Inc.; and Vertos Medical Inc. He is on the speakers bureau of Jazz Pharmaceuticals, Inc.; Medtronic, Inc.; and Vertos Medical Inc. He serves as a consultant for Jazz Pharmaceuticals, Inc.; Medtronic, Inc.; Spinal Modulation; and Vertos Medical Inc.

Dr. Grigsby has disclosed that he has received research and grant support from Alfred Mann Foundation; Boston Scientific; Collegium Pharmaceutical; CNS Therapeutics, Inc.; Jazz Pharmaceuticals, Inc.; Medtronic, Inc.; myoscience; NeurAxon Inc.; Spinal Restoration, Inc.; and St. Jude Medical, Inc. He is on the speakers bureau of Medtronic, Inc.; and Salix Pharmaceuticals, Inc. He serves as a consultant for Abbott; Alfred Mann Foundation; Cervel Neurotech, Inc.; Covidien; CNS Therapeutics; Cumberland Pharmaceuticals Inc.; Flowonix Medical; Jazz Pharmaceuticals, Inc.; Mainstay Medical; Medtronic, Inc.; myoscience; Neurophage Pharmaceuticals; Nevro Corp.; Palyon Medical Corp.; St. Jude Medical, Inc.; Spinal Modulation; VertiFlex Inc.; Vertos Medical Inc.; Xalud Therapeutics, Inc. He is a shareholder of Medtronin, Inc.; Nervo Corp.; and Spinal Modulation.

Monique Johnson, MD, CCMEP (planning committee) has nothing to disclose.

Joy Bartnett Leffler, MLA, NASW, CSE (planning committee) has nothing to disclose.

Sandra Haas Binford, MAEd (planning committee) has nothing to disclose.

Sharon Tordoff, CCMEP (planning committee) has nothing to disclose.
CME Outfitters, LLC, the faculty, and Jazz Pharmaceuticals, Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Equal Opportunity Statement: CME Outfitters reserves the right to cancel this program due to unforeseen circumstances. In the unlikely event of such cancellation, CME Outfitters will not be responsible for travel expenses incurred by the participant.

About CME Outfitters, LLC
CME Outfitters (CMEO) is a leading accredited provider in continuing medical education. CMEO develops and distributes live, recorded and web-based, outcomes- and evidence-based educational activities to thousands of clinicians each year and offers expert accreditation and outcome services for non-accredited organizations. CME Outfitters focuses on delivering education to specialty audiences, with strong expertise in neuroscience, inflammatory, infectious, and autoimmune diseases, and cardiovascular disease. For a complete list of certified activities and more information, visit or call 877.CME.PROS (877.263.7767).

“CME Outfitters … Improving Clinical Behavior … One Change at a Time”

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Haley Hoffman
CME Outfitters LLC
(614) 328-4529
Email >
Visit website